Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cue Biopharma (CUE) Operating Expenses (2018 - 2025)

Historic Operating Expenses for Cue Biopharma (CUE) over the last 8 years, with Q3 2025 value amounting to $9.7 million.

  • Cue Biopharma's Operating Expenses fell 1980.91% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.3 million, marking a year-over-year decrease of 1804.82%. This contributed to the annual value of $50.8 million for FY2024, which is 1188.78% down from last year.
  • As of Q3 2025, Cue Biopharma's Operating Expenses stood at $9.7 million, which was down 1980.91% from $11.6 million recorded in Q2 2025.
  • Cue Biopharma's Operating Expenses' 5-year high stood at $16.1 million during Q4 2021, with a 5-year trough of $9.7 million in Q3 2025.
  • Over the past 5 years, Cue Biopharma's median Operating Expenses value was $13.5 million (recorded in 2023), while the average stood at $13.5 million.
  • Per our database at Business Quant, Cue Biopharma's Operating Expenses skyrocketed by 4225.2% in 2021 and then plummeted by 2839.07% in 2024.
  • Cue Biopharma's Operating Expenses (Quarter) stood at $16.1 million in 2021, then dropped by 7.0% to $15.0 million in 2022, then rose by 4.24% to $15.7 million in 2023, then dropped by 28.39% to $11.2 million in 2024, then dropped by 13.07% to $9.7 million in 2025.
  • Its Operating Expenses was $9.7 million in Q3 2025, compared to $11.6 million in Q2 2025 and $12.7 million in Q1 2025.